Global Needle-Free Injection System Market Research Report 2022 - Market Size, Current Insights and Development Trends
SKU ID :Maia-20996253 | Published Date: 31-May-2022 | No. of pages: 122Description
Needle-free injection systems are used to administer drugs and vaccines to patients without penetrating the skin.
The Needle-Free Injection System market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Needle-Free Injection System market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Needle-Free Injection System market.
Major Players in the Needle-Free Injection System market are:
Valeritas, Inc
Medical International Technology Inc
Endo Pharmaceuticals Inc
Glide Pharmaceutical
PenJet(R)
PharmaJet
BD
Crossject
InsuJet
Portal Instruments
Bioject Medical Technologies Inc
Amico Group
InsuJet
Antares Pharma
INJEX Pharma AG
National Medical Products Co. Ltd.
On the basis of types, the Needle-Free Injection System market is primarily split into:
Powder-Based Needle Free Injectors
Liquid-Based Needle Free Injectors
Depot-Based Needle Free Injectors
On the basis of applications, the market covers:
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology companies
Other End Users
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
2021
The Needle-Free Injection System market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Needle-Free Injection System market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Needle-Free Injection System market.
Major Players in the Needle-Free Injection System market are:
Valeritas, Inc
Medical International Technology Inc
Endo Pharmaceuticals Inc
Glide Pharmaceutical
PenJet(R)
PharmaJet
BD
Crossject
InsuJet
Portal Instruments
Bioject Medical Technologies Inc
Amico Group
InsuJet
Antares Pharma
INJEX Pharma AG
National Medical Products Co. Ltd.
On the basis of types, the Needle-Free Injection System market is primarily split into:
Powder-Based Needle Free Injectors
Liquid-Based Needle Free Injectors
Depot-Based Needle Free Injectors
On the basis of applications, the market covers:
Hospitals and Clinics
Homecare Settings
Research Laboratories
Pharmaceutical and Biotechnology companies
Other End Users
Major Region
s or countries covered in this report:United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years:
2017-2021Base Year:
2021Estimated Year:
2022Forecast Period:
2022-2029TOC
Tables & Figures
Companies
- PRICE
-
$3450$6900$4600Buy Now